REQUEST A DEMO
Total
USD $0.00
Search more companies

Sadar Laboratories Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sadar Laboratories Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sadar Laboratories Private Limited is an enterprise based in India. Its main office is in Gurgaon. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Sadar Laboratories Private Limited was incorporated on April 04, 1989. The company’s latest financial report indicates a net sales revenue drop of 14.7% in 2025. Its’ total assets recorded a growth of 6.67%. In, 2025, the company’s net profit margin decreased by 0.63%.

Legal Address
A-25/16Rozka Meo Sohna
Gurgaon; Haryana; Postal Code: 000000

Contact Details: Purchase the Sadar Laboratories Private Limited report to view the information.

Website: https://www.sadarlaboratories.co m/

Basic Information
Registered Capital:
Purchase the Sadar Laboratories Private Limited report to view the information.
Financial Auditors:
Purchase the Sadar Laboratories Private Limited report to view the information.
Incorporation Date:
April 04, 1989
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Sadar Laboratories Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-14.7%
Total Operating Revenue
-14.66%
Operating Profit
-41.94%
EBITDA
-16.39%
Net Profit/Loss for the Period
-40.44%
Total Assets
6.67%
Total Equity
6.22%
Operating Profit Margin
-0.98%
Net Profit Margin
-0.63%
Return on Equity (ROE)
-4.59%
Debt / Equity
0%
Quick Ratio
0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?